CAS: 2101626-26-8
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide REF: AN-AG01KDXUCAS: 2101626-26-8 | 98% | A consultar | Qui 23 Mai 24 |
 | HPGDS inhibitor 2 REF: TM-T7948CAS: 2101626-26-8 | 99.82% | 112,00 €~2.656,00 € | Qui 30 Mai 24 |
 | HPGDS inhibitor 2 REF: 3D-BJD62626CAS: 2101626-26-8 | Min. 95% | A consultar | Sex 05 Jul 24 |
![7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide](https://static.cymitquimica.com/products/AN/thumb/AG01KDXU.jpg)
7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide
CAS:2101626-26-8
Fórmula:
C20H24F2N2O3
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
378.4130
Ref: AN-AG01KDXU
| 1mg | 225,00 € | |
| 5mg | 533,00 € | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Maio de 2024
HPGDS inhibitor 2
CAS:2101626-26-8
HPGDS inhibitor 2 (GSK-2894631A) is a potent, selective hematopoietic prostaglandin D synthase (h-pgds) inhibitor, IC50 …
Fórmula:
C20H24F2N2O3
Pureza:
99.82%
Cor e Forma:
Solid
Peso molecular:
378.41
Ref: TM-T7948
| 1mg | 112,00 € | |
| 5mg | 269,00 € | |
| 10mg | 423,00 € | |
| 25mg | 699,00 € | |
| 50mg | 985,00 € | |
| 100mg | 1.336,00 € | |
| 500mg | 2.656,00 € | |
| 1ml*10 (DMSO) | 296,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 30 de Maio de 2024
HPGDS inhibitor 2
CAS:2101626-26-8
HPGDS inhibitor 2 is a histone deacetylase (HDAC) inhibitor that attenuates the production of prostaglandin …
Fórmula:
C20H24F2N2O3
Pureza:
Min. 95%
Peso molecular:
378.41 g/mol
Ref: 3D-BJD62626
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 5 de Julho de 2024
